BGM Group LtdNASDAQ:BGM
- LAST PRICE7.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.7800/ 1
- Ask / Lots7.1000/ 1
- Open / Previous Close--- / 7.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BGM |
|---|---|---|
| 10:22 ET | 100 | 7.09 |
| 11:34 ET | 100 | 6.74 |
| 12:44 ET | 500 | 7 |
| 12:46 ET | 500 | 7 |
| 01:33 ET | 100 | 7 |
| 03:08 ET | 100 | 7 |
| 03:15 ET | 200 | 6.79 |
| 03:30 ET | 100 | 7 |
| 03:32 ET | 100 | 7 |
Oct 29, 2024
Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd., from 8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
8:00AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BGM Group Ltd | 50.6M | -6.4x | --- |
Microalliance Group Inc | 36.6M | 4.4x | --- |
Integrated Biopharma Inc | 9.8M | 24.9x | -42.26% |
Inyx Inc | 50.0 | 0.0x | --- |
CASI Pharmaceuticals Inc | 70.4M | -2.4x | --- |
Health-Chem Corp | 1.2K | 0.0x | --- |
Company Information
BGM Group Ltd, formerly Qilian International Holding Group Ltd, is a company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The Company operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. The Company's main brand is Qilian Shan. The Company principally operates its businesses within the domestic market.
Contact Information
- Headquarters
- No. 152 Hongliang East 1St Street No. 1703, Tianfu New DistrictJIUQUAN, GNS, China 610200
- Phone
- 937-268-9523
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Zhanchang Xin
- Chief Financial Officer, Director
- Haiping Shi
- Independent Director
- Ming Jing
- Independent Director
- Yixuan Sun
- Independent Director
- Qingling Zhang
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $50.6M |
|---|---|
Revenue (TTM) | $29.9M |
Shares Outstanding | 7.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.43 |
EPS | $-1.10 |
Book Value | $5.98 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -11.72% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
